Table 1.
Cutaneous and extracutaneous manifestations (n = 36)
| Variables | Values, n (%) |
|---|---|
| Morphology | |
| Erythematous papules | 24 (66.67) |
| Purpuric macules | 16 (44.44) |
| Both | 4 (11.11) |
| Erosion | 5 (13.8) |
| Swelling | 6 (16.67) |
| Distribution | |
| Hands | 2 (5.55) |
| Feet | 35 (97.22) |
| Both | 1 (2.78) |
| Laterality | |
| Unilateral | 20 (41.67) |
| Bilateral | 21 (58.33) |
| Symmetric | 10 (47.62) |
| Asymmetric | 11 (52.38) |
| Symptomatology | |
| Pruritus | 14 (38.89) |
| Pain | 8 (22.22) |
| Asymptomatic | 18 (50.00) |
| Extracutaneous manifestations (n = 11) | |
| Frequency | 11 (30.55) |
| Type | |
| Respiratory | 7 (63.64) |
| Non-respiratory | 4 (36.36) |
| Latency period (d) | 12.62 |
| Symptoms | |
| Cough | 7 (63.64) |
| Fever | 3 (27.27) |
| Diarrhea, nausea and vomiting | 3 (27.27) |
| Asthenia and myalgia | 2 (18.18) |